PROTEINURIA AFTER PIG KIDNEY XENOTRANSPLANTATION: A POTENTIAL UNIFYING HYPOTHESIS LINKING MECHANICAL, INNATE, AND ADAPTIVE INJURY PATHWAYS

Résumé fourni par la source

Persistent proteinuria remains a major barrier to successful pig-to-nonhuman primate (NHP) kidney xenotransplantation and may become an important issue in clinical renal xenotransplantation. However, published human renal xenotransplant reports to date have not established severe proteinuria as a consistent clinical finding, and its relevance in living human recipients should therefore be regarded as an important unresolved question. In pig-to-NHP models, severe proteinuria may also be accompanied by urinary loss of therapeutic monoclonal antibodies, including anti-CD154, potentially compromising rejection prophylaxis. Proteinuria in this setting may occur in association with heterogenous and overlapping patterns of immune-mediated and non-immune mediated injury, including rejection-associated endothelial, microvascular, and humoral lesions such as thrombotic microangiopathy, capillaritis, C4d deposition, and xenograft glomerulopathy. Hemodynamic mismatch should currently be regarded as a possible but unproven contributor rather than a dominant initiating trigger. We therefore propose a unifying hypothesis based on an evidence-informed, testable framework rather than a definitive causal cascade, which we hope will stimulate discussion. Clarifying the dominant mechanisms in individual cases, correlating proteinuria with biopsy findings, and prospectively monitoring urinary drug loss will be essential for developing rational preventive and therapeutic strategies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.